EVX-02-arkiv - BioStock

Evaxion unveils genetic adjuvant technology to boost vaccines

Evaxion unveils genetic adjuvant technology to boost vaccines

7 June, 2023

Per Norlén, CEO Evaxion

Evaxion to sharpen focus and launch new platform

3 April, 2023

Evaxion asset management

Evaxion Biotech Secures Equity Financing of up to 40 MUSD

10 June, 2022

Evaxion positive clinical momentum

Evaxion Biotech shows strong clinical momentum in Q1

16 May, 2022

evaxionprospects

Evaxion completes EVX-02 clinical trial recruitment

15 March, 2022

Capital injection to financeEvaxion Biotechs phase IIb studies

Capital injection sets Evaxion Biotech up for phase IIb trials

25 November, 2021

Co-founder and CBO Niels Møller Evaxion Biotech

Evaxion Biotech leverages AI to fight cancer and infectious diseases

24 September, 2021